Hemp Stocks

    ACB / Aurora Results Q4-2018 und Fical Year 2018

    Danke at Shanik82 für Info oben.


    Aurora s. Link, Text ist lang, aber super *clapping*:


    https://www.newswire.ca/news-r…iscal-year-694175781.html



    Presse / Kurzfassung:


    By


    Published: Sept 24, 2018 6:10 p.m.


    Tech reporter


    Aurora Cannabis Inc. ACBFF, +2.64% ACB, +3.63% released fiscal fourth-quarter earnings late Monday and confirmed its intention to list stock on a "senior" U.S. exchange such as the Nasdaq or the New York Stock Exchange. "Listing our shares on a senior U.S. exchange reflects the level of corporate and business maturity and our high-paced execution," Aurora Chief Executive Terry Booth said. "This listing provides access to a broader investor audience who gain the opportunity to participate in our continued success." The company's top line grew 223% to C$19.1 million, up from C$5.9 million in the year-earlier quarter. Aurora logged earnings of C$79.9 million, up from losses of C$4.8 million in last year's quarter; in its financial statements Aurora said the quarter's profits were related to unrealized non-cash gains on derivatives and other marketable securities. Gross profit was C$20.6 million, up from C$5.8 million in the year-ago quarter. The company said it produced 2,212 kilograms of pot and sold 1,617 kilograms, up 90% and 114% respectively compared with the year-earlier period. Aurora stock is listed on the pink sheets in the U.S. and on the TSX. Toronto-listed shares have gained 28% this year, as the S&P 500 index SPX, -0.35% rose 9.2%.


    Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.


    Quelle:https://www.marketwatch.com/st…9-24?mod=newsviewer_click

    Aurora / Ergebnis

    Emil hat am 25.09.2018 08:50 geschrieben:


    Danke @ Emil für Info


    Ist echt gut gekommen *smile* *drinks* *dirol* , hier noch was:


    https://www.newswire.ca/news-r…ry-leaders-694257241.html

    Pot stocks take a hit as infamous short seller targets the space


    External Content www.youtube.com
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.


    ....bezieht sich noch auf CRONOS ....also nicht ganz frisch - aber ich meine hörenswert, Andrew Left der Shortseller hat mich einiges gekostet...

    Aurora interessant


    Da hat noch jemand das Potential gesehen, Artikel von gestern,Dienstag - einfach mal anschauen...


    Aurora Cannabis May Be About To Go Ballistic


    Oct. 2, 2018 2:28 PM ET


    Summary


    It wouldn't surprise me to see its share price double by the end of 2018.


    The company will soon be listed on a major exchange, attracting much more investment.


    Upcoming Canadian legalization will be a major tailwind for Aurora.


    Latest earnings confirm company's strategy and execution is paying off.


    [Blocked Image: https://static.seekingalpha.com/uploads/2018/10/1/9642931-1538416534183098.jpg] source: Seeking Alpha


    Aurora Cannabis (OTCQX:ACBFF) has a lot going for it as the macro elements in the industry are favorable to the company, even as its strategy is paying off for shareholders, evidenced by its latest quarter, where it produced some great numbers.


    With its large production capacity, the upcoming legalization of cannabis in Canada, the announcement it will soon be listed on a major U.S. exchange, its improved performance, and growing interest from large companies outside the sector, I believe Aurora Cannabis could at least double by the end of 2018.


    Latest numbers


    Revenue in the 2018 fiscal fourth quarter came in at $19.1 million, up 19 percent sequentially, and 223 percent year-over-year, beating the $18 million in revenue generated for all of fiscal 2017.


    Full-year revenue was reported at $55.2 million, up over 200 percent over 2017, with revenue from cannabis accounting for $42.8 million of that, a gain of 169 percent.


    Medical cannabis gross margin jumped to 74 percent, up from the 58 percent in the same reporting period last year. The company attributed that to higher dried cannabis prices and a improved product mix that included more oil products that enjoy higher prices. Oils sales accounted for over 31 percent of revenue in the reporting period, up 20 percent from the prior quarter.


    The average net selling price of dried cannabis per gram for full-year 2018 increased from $6.47 last year to $7.65 per gram.

    Große Getränkehersteller entdecken Cannabis

    Getränkegiganten, die einen Hanf-Boom unterstützen.
    Die Milliarden-Dollar-Getränkegiganten haben ihre Augen auf eine völlig neue Industrie gerichtet, eine Branche, von der sie befürchten, dass sie sie bald verschlingen wird, wenn sie nicht weiterkommt.


    Also, wenn du denkst, dass du den Cannabisboom verpasst hast ... Jetzt ist vielleicht die Zeit für dich, rein zu kommen.


    Quelle:


    http://www.baystreet.ca/articl…s-Backing-A-Cannabis-Boom


    Nebenbei noch ein Artikel aus dem heutigen Aktionär


    http://www.deraktionaer.de/akt…ntdown-laeuft--400420.htm

    Aurora on th NYSE

    http://www.aktiencheck.de/exkl…vor_Aktienanalyse-9062669


    News von Aurora:


    Aurora Cannabis Announces Application to List on the NYSE


    EDMONTON, Oct. 9, 2018 - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), announced today that the Company has filed an application to list its common shares on the New York Stock Exchange ("NYSE").


    Listing of the Company's common shares on the NYSE remains subject to the approval of the NYSE and the satisfaction of all applicable listing and regulatory requirements. Aurora anticipates that, subject to receipt of all required approvals, trading in its common shares on the NYSE will commence before the end of October 2018. In advance of the intended listing, the Company has filed a Form 40-F Registration Statement with the United States Securities and Exchange Commission.


    Aurora's shares will trade on the NYSE under ticker symbol "ACB", the same symbol the Company's common shares currently, and will continue to, trade under on the Toronto Stock Exchange (TSX). Aurora will also continue to trade on the OTCQX under the ticker symbol "ACBFF" until completion of the NYSE listing. Upon receipt of all required approvals and completion of the formal listing process, the Company will publicly announce its first trading date on the NYSE. Aurora furthermore intends to voluntarily delist its shares from the OTCQX at such time.


    "Through our NYSE listing, Aurora joins an established group of mature global brands with improved access and exposure to an engaged international institutional investor audience," said Terry Booth, CEO of Aurora. "Aurora's high-paced execution has made it one of the world's leading cannabis companies. We have grown from being a licensed producer with a single facility, to a horizontality differentiated and vertically integrated global organization with a funded production capacity in excess of 500,000 kg a year, sales and operations on five continents, and a team of more than 1,500 employees."


    Mr. Booth added: "Our purpose-built, indoor grow facilities, designed to meet the stringent requirements for furnishing product to international markets, have made Aurora the largest supplier of medical cannabis in Europe. We are also well-prepared for the launch of the domestic adult consumer use market in Canada with a portfolio of strong consumer brands and coast-to-coast provincial supply arrangements covering 98% of the Canadian population. I am proud of our achievements to date, and look forward to updating the investor community as we continue to execute on our aggressive growth strategy."


    About Aurora


    Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 500,000 kg per annum and sales and operations in 18 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.


    Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at ultra-low costs. Intended to be replicable and scalable globally, these production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and ultra-low per gram production costs. Each of Aurora's facilities is built to meet EU GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland (formerly Pedanios), have achieved this level of certification.


    In addition to the Company's rapid organic growth and strong execution on strategic M&A, which to date includes 15 companies – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, Agropro, Borela, and the pending acquisition of ICC Labs – Aurora is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD), Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste Technologies Inc. (TSXV: N), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).


    Aurora's Common Shares trade on the TSX under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.


    For more information about Aurora, please visit our investor website, investor.auroramj.com, Twitter, Facebook or Instagram


    Terry Booth, CEO
    Aurora Cannabis Inc.

    ACB & Co.

    petra129 hat am 17.10.2018 12:03 geschrieben:


    Quote

    17. Oktober ...wie geht es jetzt wohl weiter? buy on rumours sell on news? ich hoffte es gehe gestern noch einmal tüchtig hoch - war nix!

    Derzeit wird erstmal mächtig in Canada verkauft. Gewinnmitnahmen. Abwarten wie es sich weiter entwickelt, denke ich, ist wohl momentan das Beste.


    Bin dabei, bleibe dabei, denn der Cannabis-Sektor ist und bleibt spannend. Hier tut sich sehr viel und die Zukunftsaussichten sind mMn rosig.


    Viel Erfolg den Investierten.

    Aurora-News ACB

    Danke euch, habe auch noch was,


    ganz frisch:


    Aurora Cannabis Receives Sales License for Aurora Sky Facility


    Softgel Sales License Granted at Aurora Vie - New Licenses Significantly Increase Product Availability for Medical and Adult Consumer-Use Markets


    EDMONTON, Oct. 17, 2018 - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that its Aurora Sky ("Sky") facility has been granted its sales license by Health Canada, significantly increasing availability of both dried flower and derivative cannabis products across all cannabis markets the Company is targeting.


    The Company also announced today that it has received a sales license from Health Canada, permitting the sale of cannabis softgel capsules produced at its state-of-the-art Aurora Vie facility located in Pointe-Claire, Québec. Aurora and Capcium Inc. ("Capcium"), the Montreal-based manufacturer that specializes in high-volume softgel encapsulation have already commenced production of softgel capsules, which are targeted at the medical, wellness, and adult consumer use markets. The Company anticipates softgels to become a high volume, high margin product within all of its target markets. The Company holds a 19.99 per cent ownership stake in Capcium and is Aurora's exclusive manufacturer of cannabis softgel products in North America.


    "These new sales licenses are a game changer for Aurora, dramatically increasing product availability and positioning us well to serve the rapidly growing domestic and international cannabis markets," said Terry Booth, CEO of Aurora. "With adult consumer use sales beginning in Canada today, these additional licenses enable Aurora to rapidly scale-up production to service the high growth anticipated for this new market. As the first of our "Sky Class" facilities, Aurora Sky is substantially differentiated from traditional indoor and greenhouse grow facilities because of its use of advanced technologies and automation that deliver industry-leading yields. This allows us to consistently produce an abundant supply of high-quality cannabis and derivatives at sustainably low production costs, anticipated to be well below $1 per gram."


    Mr. Booth added: "We're exceptionally proud of our team's efforts in completing these milestones and look forward to accelerating our growth as our facilities continue to ramp-up to full capacity."


    Strategically located at the Edmonton International Airport, Aurora Sky is the world's largest and most technologically advanced cannabis hybrid-indoor production facility constructed to date. Designed by Aurora Larssen Projects and built to EU GMP specifications, the facility measures 800,000 square feet, and incorporates a high degree of automation, full control of environmental variables, and sophisticated yield optimizing technologies, to produce consistent, high-quality, medical grade cannabis at sustainably low production costs.


    Aurora Sky, which received its first production license in January, is rapidly ramping up to full capacity of over 100,000 kg per annum, which the Company anticipates reaching around year end. At full capacity, the Company anticipates one harvest every 3.5 days, resulting in over 6 harvests per room per year, comparing very favorably with traditional greenhouses and other grow facilities. In addition to cultivation, Aurora Sky also features processing, bottling, and automated packaging and labeling capacity, enabling the Company to service market demand for high margin derivative products.


    To date, the mother room and four flower rooms, each measuring 34,000 square feet, have been licensed for production. The rooms have now been populated using the automated systems, which were commissioned successfully. Presently, approximately 120,000 plants are growing in the facility's licensed flower rooms. The Company has submitted license applications for additional flower rooms and all ancillary system rooms, and will be applying for further production licenses until the entire facility is licensed and populated, anticipated for late November or early December.


    About Aurora


    Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 500,000 kg per annum and sales and operations in 18 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.


    Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at ultra-low costs. Intended to be replicable and scalable globally, these production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and ultra-low per gram production costs. Each of Aurora's facilities is built to meet EU GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland (formerly Pedanios), have achieved this level of certification.


    In addition to the Company's rapid organic growth and strong execution on strategic M&A, which to date includes 15 companies – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, and MED Colombia, Agropro, Borela, and the pending acquisition of ICC Labs – Aurora is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).


    Aurora's Common Shares trade on the TSX under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.


    For more information about Aurora, please visit our investor website: investor.auroramj.com


    Terry Booth, CEO
    Aurora Cannabis Inc.



    Presse.


    Aurora Cannabis celebrates Canadian pot legalization


    2018-10-17 08:59 ET - News Release


    Ms. Heather MacGregor reports


    AURORA CANNABIS CELEBRATES ADULT CONSUMER LEGALIZATION IN CANADA


    On this historic day, Aurora Cannabis Inc. is proud to celebrate consumer legalization by commending governments of all levels for their commitment to bringing an end to the prohibition of cannabis for adult consumer use, and acknowledging the decades of activism and effort that have led to this moment.


    With retail sales beginning in provinces across the country today, Canada is the first G20 country to take this historic, transformative step. The country now stands as the world leader in cannabis public policy, innovation and acceptance.


    "It's a proud day to be Canadian," said Aurora chief executive officer Terry Booth. "For the last three years, the world has watched as we prepared for legalization as an industry and a country. The end of prohibition is a victory for advocates, for activists, for science, for personal freedom and for common sense. The Canadian cannabis community is strong, smart and resilient. Aurora respect and honour the will of advocates and activists who fought and continue to fight unjust laws that limited the righteous adult access to cannabis.


    Aurora is one of Canada's leading licensed producers and a developer of high-quality cannabis products to markets across the country and around the world. This thriving new Canadian industry has created jobs and prosperity across Canada and Canada is setting the global standard in crop production, product quality, cannabis science and patient care.


    Global leaders


    Canada has now become the second country in the world following Uruguay to fully legalize adult consumer cannabis. On the medical side at least 31 countries around the world have federally regulated medical cannabis.


    "Today is a day the world will not soon forget," said Neil Belot, Aurora's chief global business development officer. "Canada has taken an evidence-based approach to legalization after nearly a century-long misstep, and as a result we have made our great country a healthier and safer place for our families, communities and international visitors. We call on our cannabis advocates around the world to follow Canada's lead. Aurora's science team will continue to support and advance evidence-based, sensible, public-health approaches to all forms of cannabis policy, particularly as it relates to the commercial, food-based, wellness, medical, research and adult consumer use sectors."


    Medical cannabis comes first at Aurora


    While legalization of cannabis for adult consumer use is an exciting milestone, as Canada's leading licensed producer of medicinal cannabis, together with wholly owned subsidiaries CanniMed and MedReleaf, Aurora reconfirms its commitment to its medical patients, including the Canadian veteran community.


    "Cannabis as a medicine is a need, not an option," said Aurora's chief corporate officer Cam Battley. "Our goal will always be to provide our patients with the greatest choice and flexibility in reliable, high-quality cannabis. We also commit to working with advocates, industry and governments across Canada to push for tax fairness for medical cannabis, something of critical importance to patients with chronic health conditions who find symptom relief in medical cannabis, but who often lack sufficient funds to afford the medication that helps them most."


    Aurora and MedReleaf consumer brands available across Canada


    Aurora is proud to work with government and private retailers across Canada to supply a broad range of dried flower and higher margin products such as prerolls, oils and capsules. Aurora's integrated teams and its strategic partners have entered into supply arrangements with provinces and territories accounting for more than 98 per cent of the Canadian population. The Aurora and MedReleaf brands, including San Rafael '71 and AltaVie, are expected to have a strong presence across the country, positioning the company well for rapid growth.


    "We are proud of the science and innovation that have gone into developing our adult-use brands and expect them to resonate well with consumers across Canada," said Darren Karasiuk, executive vice-president, global adult usage. "Both Aurora and MedReleaf have developed expertise and technology to consistently grow premium-grade cannabis for discerning adults and we are confident that adult consumers will soon see how we differentiate ourselves from the others."


    Continued outreach and education


    Over the last few years, Aurora has provided comprehensive outreach, counseling and educational services to patients and physicians in the Canadian medical system through its wholly owned subsidiary CanvasRx.


    Mr. Booth added: "With adult consumer use sales beginning today, our efforts to provide much needed product education and services to patients, consumers, physicians, pharmacists and retail operators will continue in earnest. New cannabis consumers, and those with limited past experience, will require comprehensive, practical information on the effects of various cannabis products, and the responsible, informed use of them."


    About Aurora Cannabis Inc.


    Headquartered in Edmonton, Alta., Canada, with financed capacity in excess of 500,000 kilograms per annum and sales and operations in 18 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.


    We seek Safe Harbor.


    © 2018 Canjex Publishing Ltd. All rights reserved.

    ACB & Co.

    @Petra, den Blick nach vorne richten und nicht mehr dem Verpassten hinterher jammern. Es gibt so viele Möglichkeiten; eine davon ist eben Aurora. Das Listing für die NYSE ist für Ende Oktober geplant, dann sollte es nochmals einen Kursschub nach oben geben. Lassen wir uns überraschen. Und danke für den Link.


    Lorenz, danke für den Link.


    Derzeit wird man überhäuft mit Informationen. Viele Medien schreiben über die neu entstandenene Industrie, sprich über den Cannabis-Sektor. Und so möchte ich auch nochmal etwas hinzufügen.


    https://www.finanzen.net/nachr…der-tilray-effekt-6713926


    Einen schönen Tag und viel Erfolg beim Investieren.

    Auswertung kanadische Lizenzen

    Nach langer Zeit melde ich mich auch wieder mal zu Worte.... Falls jemand eine Auswertung von sämtlichen kanadischen Lizenzen benötigt, kann sich gerne bei mir melden.

    ACB & C0. / ACB-NYSE Start 23.Okt.

    Canada's Aurora Cannabis Stock To Start Trading On The NYSE Oct. 23 -- MarketWatch


    http://www.marketwatch.com/newsviewer


    Canadian weed company Aurora Cannabis Inc. said Thursday its shares have been approved for trading on the New York Stock Exchange and will start to do so on October 23. The stock will trade under the ticker symbol "ACB". The shares are currently traded on the Toronto Stock Exchange as well as on the U.S. over-the-counter market. The news comes one day after Canada fully legalized cannabis for adult recreational use, the first G-7 country to do so and only the second in the world to do so after Uruguay. Aurora shares were not yet active premarket, but have gained 38.4% in 2018, while the S&P 500 has gained 5.1%.


    GoogleÜbersetzung:


    Die kanadische Graspflanze Aurora Cannabis Inc. gab am Donnerstag bekannt, dass ihre Aktien für den Handel an der New Yorker Börse zugelassen sind und am 23. Oktober beginnen werden. Die Aktie wird unter dem Tickersymbol "ACB" gehandelt. Die Aktien werden derzeit sowohl an der Toronto Stock Exchange als auch am US-amerikanischen Over-the-Counter-Markt gehandelt. Die Nachrichten kommen einen Tag, nachdem Kanada Cannabis für den Freizeitgebrauch für Erwachsene vollständig legalisiert hat, das erste G-7-Land, das dies tut, und nur das zweite weltweit nach Uruguay. Die Aurora-Aktie war vorbörslich noch nicht aktiv, hat aber im Jahr 2018 um 38,4% zugelegt, während der S & P 500 5,1% zugelegt hat.

    echt beschi**en